UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

Hepatology (Baltimore, Md.), 2018-02, Vol.67 (2), p.549-559

2018

Volltextzugriff (PDF)

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

Clinical gastroenterology and hepatology, 2018-03, Vol.16 (3), p.417-426

2018

Volltextzugriff (PDF)

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

Gastroenterology (New York, N.Y. 1943), 2016-06, Vol.150 (7), p.1590-1598

2016

Volltextzugriff (PDF)

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

Hepatology (Baltimore, Md.), 2018-10, Vol.68 (4), p.1298-1307

2018

Volltextzugriff (PDF)

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease

Kidney international reports, 2019-02, Vol.4 (2), p.257-266

2019

Volltextzugriff (PDF)

Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib

Journal of hepatology, 2019-01, Vol.70 (1), p.133-141

2019

Volltextzugriff (PDF)

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

The New England journal of medicine, 2014-12, Vol.371 (25), p.2375-2382

2014

Volltextzugriff (PDF)

A Cross-Sectional Study of Stress and the Perceived Style of Decision-Making in Clinicians and Patients With Cancer

Health services research and managerial epidemiology, 2019-01, Vol.6, p.2333392819855397

2019

Volltextzugriff (PDF)

Dasabuvir (ABT333) for the treatment of chronic HCV genotype I: a new face of cure, an expert review

Expert review of anti-infective therapy, 2016-02, Vol.14 (2), p.157-165

2016

Volltextzugriff (PDF)

Long Term Success Rates and Complications of Metallic and Plastic Stents in Post Transplant Bile Duct Strictures: A Large Single Center Experience

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1132-S1132

2017

Volltextzugriff (PDF)

Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study

Journal of gastrointestinal oncology, 2017-10, Vol.8 (5), p.799-807

2017

Volltextzugriff (PDF)

Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center

Journal of gastrointestinal oncology, 2021-08, Vol.12 (4), p.1718-1731

2021

Volltextzugriff (PDF)

Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials

Liver international, 2018-06, Vol.38 (6), p.1010-1021

2018

Volltextzugriff (PDF)

Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis

Gastroenterology (New York, N.Y. 1943), 2020-11, Vol.159 (5), p.1985-1987.e4

2020

Volltextzugriff (PDF)

Hepatic Proton Density Fat Fraction Correlates with Histologic Measures of Steatosis and is Responsive to Change in those Measures in a Multi-Center Nonalcoholic Steatohepatitis Clinical Trial

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1074-S1074

2017

Volltextzugriff (PDF)

What we have learned from 5 cases of permanent capsule retention

Gastrointestinal endoscopy, 2006-08, Vol.64 (2), p.283-287

2006

Volltextzugriff (PDF)

Mo1040 The Impact of Hispanic Ethnicity on Clinical Presentation, Treatment and Outcomes Among Patients With Hepatocellular Carcinoma

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-993-S-993

2014

Volltextzugriff (PDF)

Mo1848 Results of Response Guided Therapy (Rgt) Using Telaprevir Based Triple Therapy in Liver Transplant Recipients With Recurrence of Hepatitis C Virus (HCV) Infection

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-1028-S-1028

2013

Volltextzugriff (PDF)

Small-bowel masses found and missed on capsule endoscopy for obscure bleeding

Scandinavian journal of gastroenterology, 2007-01, Vol.42 (9), p.1127-1132

2007

Volltextzugriff (PDF)

837 Early Virologic Response in Patients With HCV Recurrence After Liver Transplant Treated With Triple Therapy: A Single Center Experience

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-931-S-932

2012

Volltextzugriff (PDF)

Tu1609 Sorafenib Use After Prior Surgical Resection or Transplant in Hepatocellular Carcinoma: US Regional Analysis of GIDEON

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-1087-S-1088

2014

Volltextzugriff (PDF)

Su1049 Faldaprevir Plus Pegylated Interferon Alfa-2A and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C Genotype-1 Infection: A Pooled Analysis of Two Randomized, Double-Blind Placebo-Controlled Phase III Trials (Startverso1&2)

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-974-S-974

2014

Volltextzugriff (PDF)

Su1051 Duration of Undetectable HCV RNA in Patients Treated With Faldaprevir-Deleobuvir Interferon-Free Combination Is Associated With SVR

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-975-S-975

2014

Volltextzugriff (PDF)

Su1058 Early Stopping Rules for Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Exploratory Study of Pooled Data From Phase III Trials

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-977-S-977

2014

Volltextzugriff (PDF)

Su1686 Fasting Ammonia (Nh3 ) As a Predictor of Hepatic Encephalopathy (HE) Events

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-997-S-997

2013

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(152)
Berichte
(2)

Sprache

Englisch
(154)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease

Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

A Cross-Sectional Study of Stress and the Perceived Style of Decision-Making in Clinicians and Patients With Cancer

Dasabuvir (ABT333) for the treatment of chronic HCV genotype I: a new face of cure, an expert review

Long Term Success Rates and Complications of Metallic and Plastic Stents in Post Transplant Bile Duct Strictures: A Large Single Center Experience

Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study

Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center

Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials

Screening for Nonalcoholic Fatty Liver Disease in Persons with Type 2 Diabetes in the United States Is Cost-effective: A Comprehensive Cost-Utility Analysis

Hepatic Proton Density Fat Fraction Correlates with Histologic Measures of Steatosis and is Responsive to Change in those Measures in a Multi-Center Nonalcoholic Steatohepatitis Clinical Trial

What we have learned from 5 cases of permanent capsule retention

Mo1040 The Impact of Hispanic Ethnicity on Clinical Presentation, Treatment and Outcomes Among Patients With Hepatocellular Carcinoma

Mo1848 Results of Response Guided Therapy (Rgt) Using Telaprevir Based Triple Therapy in Liver Transplant Recipients With Recurrence of Hepatitis C Virus (HCV) Infection

Small-bowel masses found and missed on capsule endoscopy for obscure bleeding

837 Early Virologic Response in Patients With HCV Recurrence After Liver Transplant Treated With Triple Therapy: A Single Center Experience

Tu1609 Sorafenib Use After Prior Surgical Resection or Transplant in Hepatocellular Carcinoma: US Regional Analysis of GIDEON

Su1049 Faldaprevir Plus Pegylated Interferon Alfa-2A and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C Genotype-1 Infection: A Pooled Analysis of Two Randomized, Double-Blind Placebo-Controlled Phase III Trials (Startverso1&2)

Su1051 Duration of Undetectable HCV RNA in Patients Treated With Faldaprevir-Deleobuvir Interferon-Free Combination Is Associated With SVR

Su1058 Early Stopping Rules for Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Treatment-Naïve Patients: Exploratory Study of Pooled Data From Phase III Trials

Su1686 Fasting Ammonia (Nh3 ) As a Predictor of Hepatic Encephalopathy (HE) Events

Suchergebnisse filtern